Table of Contents Author Guidelines Submit a Manuscript
Journal of Ophthalmology
Volume 2018 (2018), Article ID 4081874, 4 pages
https://doi.org/10.1155/2018/4081874
Research Article

Anatomical Retinal Changes after Photodynamic Therapy in Chronic Central Serous Chorioretinopathy

1Department of Ophthalmology, Gregorio Marañón University General Hospital, Madrid, Spain
2IIS-Aragón, Department of Ophthalmology, Miguel Servet University Hospital, Zaragoza, Spain
3University of Zaragoza, Zaragoza, Spain

Correspondence should be addressed to Pilar Calvo

Received 20 October 2017; Revised 4 January 2018; Accepted 9 January 2018; Published 6 February 2018

Academic Editor: Luca Di Antonio

Copyright © 2018 María Pilar Ruiz-del-Tiempo et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. Liew, G. Quin, M. Gillies, and S. Fraser-Bell, “Central serous chorioretinopathy: a review of epidemiology and pathophysiology,” Clinical & Experimental Ophthalmology, vol. 41, no. 2, pp. 201–214, 2013. View at Publisher · View at Google Scholar · View at Scopus
  2. S. S. Mudvari, M. J. Goff, A. D. Fu et al., “The natural history of pigment epithelial detachment associated with central serous chorioretinopathy,” Retina, vol. 27, no. 9, pp. 1168–1173, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. M. Wang, I. C. Munch, P. W. Hasler, C. Prünte, and M. Larsen, “Central serous chorioretinopathy,” Acta Ophthalmologica, vol. 86, no. 2, pp. 126–145, 2008. View at Publisher · View at Google Scholar
  4. A. Ross, A. H. Ross, and Q. Mohamed, “Review and update of central serous chorioretinopathy,” Current Opinion in Ophthalmology, vol. 22, no. 3, pp. 166–173, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. R. F. Spaide, L. Campeas, A. Haas et al., “Central serous chorioretinopathy in younger and older adults,” Ophthalmology, vol. 103, no. 12, pp. 2070–2080, 1996. View at Publisher · View at Google Scholar
  6. C. A. Carvalho-Recchia, L. A. Yannuzzi, S. Negrão et al., “Corticosteroids and central serous chorioretinopathy,” Ophthalmology, vol. 109, no. 10, pp. 1834–1837, 2002. View at Publisher · View at Google Scholar · View at Scopus
  7. J. M. Ruiz‐Moreno, F. L. Lugo, F. Armadá et al., “Photodynamic therapy for chronic central serous chorioretinopathy,” Acta Ophthalmologica, vol. 88, no. 3, pp. 371–376, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. U. Schmidt-Erfurth, J. Miller, M. Sickenberg et al., “Photodynamic therapy of subfoveal choroidal neovascularization: clinical and angiographic examples,” Graefe's Archive for Clinical and Experimental Ophthalmology, vol. 236, no. 5, pp. 365–374, 1998. View at Publisher · View at Google Scholar · View at Scopus
  9. M. S. Blumenkranz, N. M. Bressler, S. B. Bressler et al., “Verteporfin therapy for subfoveal choroidal neovascularization in age-related macular degeneration: three-year results of an open-label extension of 2 randomized clinical trials—TAP report no. 5,” Archives of Ophthalmology, vol. 120, no. 10, pp. 1307–1314, 2002. View at Publisher · View at Google Scholar
  10. S. B. Brown and K. J. Mellish, “Verteporfin: a milestone in ophthalmology and photodynamic therapy,” Expert Opinion on Pharmacotherapy, vol. 2, no. 2, pp. 351–361, 2001. View at Publisher · View at Google Scholar · View at Scopus
  11. W. M. Chan, T. Y. Lai, R. Y. Lai, E. W. Tang, D. T. Liu, and D. S. Lam, “Safety enhanced photodynamic therapy for chronic central serous chorioretinopathy: one-year results of a prospective study,” Retina, vol. 28, no. 1, pp. 85–93, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. J. Y. Shin, S. J. Woo, H. G. Yu, and K. H. Park, “Comparison of efficacy and safety between half-fluence and full-fluence photodynamic therapy for chronic central serous chorioretinopathy,” Retina, vol. 31, no. 1, pp. 119–126, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. A. Koytak, K. Erol, E. Coskun, N. Asik, H. Öztürk, and Y. Özertürk, “Fluorescein angiography-guided photodynamic therapy with half-dose verteporfin for chronic central serous chorioretinopathy,” Retina, vol. 30, no. 10, pp. 1698–1703, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Reibaldi, N. Cardascia, A. Longo et al., “Standard-fluence versus low-fluence photodynamic therapy in chronic central serous chorioretinopathy: a nonrandomized clinical trial,” American Journal of Ophthalmology, vol. 149, no. 2, pp. 307–315.e2, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. K. Fujita, Y. Imamura, K. Shinoda et al., “One-year outcomes with half-dose verteporfin photodynamic therapy for chronic central serous chorioretinopathy,” Ophthalmology, vol. 122, no. 3, pp. 555–561, 2015. View at Publisher · View at Google Scholar · View at Scopus
  16. F. C. Piccolino, R. R. de la Longrais, G. Ravera et al., “The foveal photoreceptor layer and visual acuity loss in central serous chorioretinopathy,” American Journal of Ophthalmology, vol. 139, no. 1, pp. 87–99, 2005. View at Publisher · View at Google Scholar · View at Scopus
  17. R. H. Loo, I. U. Scott, H. W. Flynn Jr. et al., “Factors associated with reduced visual acuity during long-term follow-up of patients with idiopathic central serous chorioretinopathy,” Retina, vol. 22, no. 1, pp. 19–24, 2002. View at Publisher · View at Google Scholar · View at Scopus
  18. Y. Ojima, M. Hangai, M. Sasahara et al., “Three-dimensional imaging of the foveal photoreceptor layer in central serous chorioretinopathy using high-speed optical coherence tomography,” Ophthalmology, vol. 114, no. 12, pp. 2197–2207.e1, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. R. M. Silva, J. M. Ruiz-Moreno, F. Gomez-Ulla et al., “Photodynamic therapy for chronic central serous chorioretinopathy: a 4-year follow-up study,” Retina, vol. 33, no. 2, pp. 309–315, 2013. View at Publisher · View at Google Scholar · View at Scopus
  20. H. Vasconcelos, I. Marques, A. R. Santos et al., “Long-term chorioretinal changes after photodynamic therapy for chronic central serous chorioretinopathy,” Graefe's Archive for Clinical and Experimental Ophthalmology, vol. 251, no. 7, pp. 1697–1705, 2013. View at Publisher · View at Google Scholar · View at Scopus
  21. H. Matsumoto, S. Kishi, T. Otani, and T. Sato, “Elongation of photoreceptor outer segment in central serous chorioretinopathy,” American Journal of Ophthalmology, vol. 145, no. 1, pp. 162–168.e1, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. U. Schlötzer-Schrehardt, A. Viestenz, G. O. Naumann, H. Laqua, S. Michels, and U. Schmidt-Erfurth, “Dose-related structural effects of photodynamic therapy on choroidal and retinal structures of human eyes,” Graefe's Archive for Clinical and Experimental Ophthalmology, vol. 240, no. 9, pp. 748–757, 2002. View at Publisher · View at Google Scholar
  23. K. Shimizu, Y. Hashimoto, K. Azuma et al., “Changes of outer retinal microstructures after photodynamic therapy for chronic central serous chorioretinopathy,” Clinical Ophthalmology, vol. 11, pp. 1505–1512, 2017. View at Publisher · View at Google Scholar